Paper
0
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates
Authors
Sara Sleiman,Tyler Hansen
Nathan Mathewson,Feng Shen,Miroslaw Kozlowski,Olga Shestova,Maksim Shestov,Danuta Jarocha,Vanessa Gonzalez,Joseph Fraietta,Hannah Thomas,Ja Swain,Raimon Duran‐Struuck,Kelly Moynihan,Paul Bessette,Chris Kimberlin,Meghana Sukthankar,Terrence Park,Andy Yeung,Ivana Djuretic
+18 authors
,Saar GillJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave